PMID: 7535939Nov 1, 1994Paper

Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma

Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
R ThomasMichael Brada

Abstract

We report the palliative effectiveness of a hypofractionated radiotherapy regimen in patients with poor prognosis high grade glioma. Thirty-eight elderly, and/or disabled patients received radiotherapy to a dose of 30 Gy in 6 fractions over 2 weeks to a planning target volume defined by the enhancing tumour and a 2-cm margin. The median survival was 6 months with a 1-year survival rate of 23%. Treatment was without acute toxicity. One month after radiotherapy, functional status, assessed using a verbally administered Barthel index, improved in 38% and remained stable in a further 39% of surviving patients. At 3 months 39% of surviving patients had improved and a further 12% remained stable. We conclude that in the poor prognostic group of patients with high grade glioma hypofractionated partial brain radiotherapy is well tolerated, convenient and provides effective palliation in a proportion of patients. Comparison with conventional radiotherapy or symptomatic care alone require further evaluation in randomised studies.

Citations

Apr 10, 2008·Journal of Neuro-oncology·Angelique E SijbenJ Gregory Cairncross
Oct 6, 2007·Medical Oncology·Meral Y SayinMuzaffer B Altundag
Oct 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E SalminenS Huhtala
Sep 21, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Normand LaperriereUNKNOWN Cancer Care Ontario Practice Guidelines Initiative Neuro-Oncology Disease Site Group
Jun 19, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J J McAleeseMichael Brada
Jul 30, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Claire PhillipsGeorge Quong
Mar 4, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·M C HulshofD González González
Aug 23, 2001·International Journal of Radiation Oncology, Biology, Physics·L PaszatE Holowaty
May 10, 2003·International Journal of Radiation Oncology, Biology, Physics·Eric L ChangMoshe H Maor
Dec 24, 2003·Clinical Oncology : a Journal of the Royal College of Radiologists·G E GerrardD Levy
May 30, 2012·Nature Reviews. Clinical Oncology·Chris JonesDarren Hargrave
Sep 10, 2002·The Lancet Oncology·Tejpal Gupta, Rajiv Sarin
Apr 8, 2014·Clinical Oncology : a Journal of the Royal College of Radiologists·R Rampling, S Erridge
Sep 16, 2014·Seminars in Radiation Oncology·Michelle FergusonGlenn Bauman
Aug 25, 2012·The British Journal of Radiology·M HingoraniA M Beavis
Jan 1, 1997·Clinical Oncology : a Journal of the Royal College of Radiologists·J M FordN M Bleehen
Jun 23, 2012·Cancer Treatment Reviews·Normand LaperriereMartin J van den Bent
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W RoaP Forsyth
Feb 19, 2000·Hematology/oncology Clinics of North America·B Zachariah, L Balducci
Feb 24, 2001·Hospital Medicine·S C Short, M Brada
Sep 1, 2005·Journal of Neuro-oncology·A MangiolaC Anile
Dec 22, 2007·Expert Review of Anticancer Therapy·Mersiha HadziahmetovicRobert Cavaliere
Aug 30, 2012·Journal of the Egyptian National Cancer Institute·Mohamed A Aboziada, Ahmed E Abo-Kresha
Feb 3, 2018·Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko·V A GerasimovP V Datsenko
Mar 25, 2005·Acta Oncologica·Tejpal Gupta, Ketayun Dinshaw
Mar 13, 2019·Cancers·Giuseppe MinnitiSergio Paolini
Feb 6, 2008·Journal of Neuro-oncology·G MinnitiR Maurizi Enrici
Aug 7, 2014·Journal of Neuro-oncology·Giuseppe Minniti, Riccardo Maurizi Enrici
Jun 10, 2020·Radiation Oncology·Jane-Chloe TroneEdouard Ollier
May 13, 2008·Expert Review of Anticancer Therapy·James W ClarkeSimon S Lo
Aug 21, 2008·Journal of Neuro-oncology·John BuattiJeffrey J Olson
Aug 7, 2021·Neuro-oncology Advances·Mathew R VoisinGelareh Zadeh
Oct 10, 2006·Critical Reviews in Oncology/hematology·Alba A BrandesAlicia Tosoni

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Radiation Oncology, Biology, Physics
G BaumanJ G Cairncross
International Journal of Radiation Oncology, Biology, Physics
L KleinbergM D Wharam
Clinical Oncology : a Journal of the Royal College of Radiologists
J M FordN M Bleehen
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
J J McAleeseMichael Brada
© 2021 Meta ULC. All rights reserved